The post-progression survival of patients with recurrent or persistent ovarian clear cell carcinoma: results from a randomized phase III study in JGOG3017/GCIG.
Asumi OkumuraTsutomu TabataNao SuzukiDaisuke AokiHideaki YahataYoshio KoteraOsamu TokuyamaKeiichi FujiwaraEizo KimuraFumitoshi TerauchiToshiyuki SumiAikou OkamotoNobuo YaegashiTakayuki EnomotoToru SugiyamaPublished in: Journal of gynecologic oncology (2021)
Our findings revealed that platinum sensitivity and primary stage are clinical factors that significantly affect PPS in patients with recurrent or persistent CCC as well as other histologic subtypes of ovarian cancer. PPS in patients with recurrent CCC should establish the basis for future clinical trials in this population.